Collection 

Lipid metabolism in the liver

Submission status
Open
Submission deadline

The liver is one of the most important regulators of systemic energy metabolism, including the coordinated uptake, storage and release of lipids. Lipid metabolism in the liver ranges from uptake of chylomicron-derived lipids and fatty acids arising from adipose tissue lipolysis, among other sources, to de novo lipogenesis, mitochondrial and peroxisomal oxidation, and lastly lipoprotein metabolism and secretion. These are only a few of the major hepatic metabolic pathways that impact metabolic homeostasis in the liver, but also systemically. Deregulation of any of these pathways has been associated with various pathologies, including non-alcoholic fatty liver disease (NAFLD) and liver cancer, as well as obesity and type 2 diabetes. Given that dysfunctional hepatic lipid metabolism is a central feature of these disease states, and that reducing lipid burden in the liver is associated with improvements in NAFLD and insulin sensitivity, it is not surprising that extensive research efforts focus on novel therapeutic strategies to improve hepatic steatosis.

This collection aims to cover a broad range of aspects related to lipid metabolism in the liver, ranging from broad discovery projects to translational and clinical aspects of targeting lipid metabolism for (patho)physiological disease states.

The topics include but are not limited to:

  • Targeting lipid metabolism for the treatment of NAFLD
  • Understanding the link between hepatic lipid metabolism and insulin resistance
  • The endocrine function of the liver – A focus on lipid release from the liver
  • Sphingolipids – Major players in hepatic insulin resistance
  • Circulating lipids as biomarkers for liver dysfunction
  • Genetic factors underlying increased lipid burden in the liver

This Collection supports and amplifies research related to SDG 3.

Submit manuscript
Manuscript editing services
3D illustration of liver damage

Editors

All articles have undergone npj Metabolic Health and Disease's standard peer review process and have been subject to all the journal’s standard policies. This includes the journal’s policy on competing interests. The Editors declare no competing interests with the submissions which they have handled through the peer review process. The peer review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.

If accepted for publication, an article processing charge applies (with standard waiver policy). If your institution or country has an open access agreement with Springer Nature, you may publish your article OA at no cost or in some cases with the costs partially funded (see details here).  

All Collections are open for submissions from all authors – and not by invitation only – on the condition that the manuscripts fall within the scope of the Collection and of npj Metabolic Health and Disease more generally.

Manuscripts submitted to an open Collection may be considered unsuitable for inclusion, particularly if they fall outside the scope of the Collection. In such cases, the authors will be notified by the editorial office and their manuscript can be considered as a regular npj Metabolic Health and Disease submission.

npj Metabolic Health and Disease’s in-house editors reserve the right to assume responsibility for the management of a Collection at any stage.